Document Detail

Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
MedLine Citation:
PMID:  22853784     Owner:  NLM     Status:  In-Data-Review    
Evidence for the efficacy and safety of intravesical onabotulinum toxin A (onabotA) injections has led to it being licensed in many countries in patients with urinary incontinence due to neurogenic detrusor overactivity resulting from spinal cord injury and multiple sclerosis, who are refractory or intolerant to the gold-standard treatment, anticholinergics. Owing to its mechanism of action, an inhibitory effect on acetylcholine release is obtained for up to 10 months, with a recommended dose of 200 units. Urinary tract infections and postvoid residual volume are the most prevalent side effects. In the case of residual volume, clean intermittent catheterization might be necessary. In patients with spinal cord injury and multiple sclerosis, it is recommended to evaluate the manual dexterity and cognitive function before onabotA injections, to ensure that the patient and caregiver are able to perform catheterization if necessary. OnabotA treatment has a beneficial effect not only on urinary symptoms but also on quality of life.
An-Sofie Om Goessaert; Karel Cmm Everaert
Related Documents :
18221934 - Comparison of the treatment outcome of pubovaginal sling, tension-free vaginal tape, an...
2925354 - Results and relevance of urodynamic studies in the management of urinary incontinence i...
17098654 - Urinary retention after haemorrhoidectomy: impact of stapled haemorrhoidectomy.
10601904 - Surgical management of recurrent stress urinary incontinence: a 12-year experience.
22038174 - The frank stinchfield award: dislocation in revision tha: do large heads (36 and 40 mm)...
6696524 - Progression of radiological changes in rheumatoid arthritis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  12     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-08-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  763-75     Citation Subset:  IM    
Continence Clinic, Department of Urology, Ghent University Hospital, De Pintelaan 185 9000, Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amnesiacs might get the gist: Reduced false recognition in amnesia may be the result of impaired ite...
Next Document:  News in aging and dementia at the 13th Pan American Congress of Neurology.